MTHFR Homozygous Mutation and Additional Risk Factors for Cerebral Infarction in a Large Italian Family

Pediatric Neurology

Volumn 40, Issue 1, 2009, Pages 63-67

  Del Balzo, Francesca ^a   Spalice, Alberto ^a   Perla, Massimo ^a   Properzi, Enrico ^a   Iannetti, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BARBITURIC ACID DERIVATIVE; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C;

ARTICLE; BRAIN INFARCTION; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; GENE MUTATION; GENERALIZED EPILEPSY; HETEROZYGOSITY; HUMAN; INFANT; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CEREBRAL INFARCTION; CHILD; EPILEPSY; FACTOR VII; FAMILY; FEMALE; FRONTAL LOBE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PARESIS; PEDIGREE; PROTEIN C; RISK FACTORS; SUBTHALAMUS; TEMPORAL LOBE;

EID: 57049127081     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.09.023     Document Type: Article

References (20)

1. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., and Costa F.F. The mutation Ala677→Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease venous thrombosis. Thromb Haemost 77 (1997) 818-821
2. Markus H.S., Ali N., Swaminathan R., Sankaralingam A., Molloy J., and Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28 (1997) 1739-1743
3. Thuillier L., Chadefaux-Vekemans B., Bonnefont J.P., et al. Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?. J Inherit Metab Dis 21 (1998) 812-822
4. Nowak-Göttl U., Sträter R., Dübbers A., Oleszuk-Raschke K., and Vielhaber H. Ischaemic stroke in infancy and childhood: role of the Arg 506 to Gln mutation in the factor V gene. Blood Coagul Fibrinolysis 7 (1996) 684-688
5. Kenet G., Sadetzki S., Murad H., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31 (2000) 1283-1288
6. Barreirinho S., Ferro A., Santos M., et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol 28 (2003) 134-138
7. Lynch J.K., Hirtz D.G., DeVeber G., and Nelson K.B. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 109 (2002) 116-123
8. Voudris K., Skardoutsou A., and Vagiakou E. Congenital microcephaly in two infants with the factor V Leiden mutation. J Child Neurol 17 (2002) 905-907
9. Duran R., Biner B., Demir M., Celtik C., and Karasalihoǧlu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 11 (2005) 83-88
10. deVeber G., Monagle P., Chan A., et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 55 (1998) 1539-1543
11. Lynch J.K., Nelson K.B., Curry C.J., and Grether J.K. Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 16 (2001) 735-744
12. Green D. Thrombophilia and stroke. Top Stroke Rehabil 10 (2003) 21-33
13. Cardo E., Monrós E., Colomé C., et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 15 (2000) 295-298
14. Nowak-Göttl U., Sträter R., Heinecke A., et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 94 (1999) 3678-3682
15. Haywood S., Liesner R., Pindora S., and Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child 90 (2005) 402-405
16. Alluri R.V., Mohan V., Komandur S., Chawda K., Chaudhuri J.R., and Hasan Q. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 12 (2005) 40-44
17. Montiel-Manzano G., de la Peña-Díaz A., Majluf-Cruz A., et al. National evaluation of the diagnosis of activated protein C resistance. [In Spanish]. Rev Invest Clin 55 (2003) 358-369
18. Kelly P.J., Rosand J., Kistler J.P., et al. Homocysteine, MTHFR 667C→T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59 (2002) 529-536
19. Yamamoto M., Hara H., and Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett 486 (2000) 159-162
20. Jin L., Caldwell R.B., Li-Masters T., and Caldwell R.W. Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol 58 (2007) 191-206